A phase 2 study of modified lenalidomide, bortezomib and dexamethasone in transplant-ineligible multiple myeloma

Elizabeth K. O'Donnell, Jacob P. Laubach, Andrew J. Yee, Tianqi Chen, Carol Ann Huff, Frank G. Basile, Philip M. Wade, Claudia E. Paba-Prada, Irene M. Ghobrial, Robert L. Schlossman, Jill N. Burke, Cynthia C. Harrington, Kathleen J. Lively, Hannah F. Lyons, Nikhil C. Munshi, Kenneth C. Anderson, Lorenzo Trippa, Paul G. Richardson, Noopur S. Raje

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'A phase 2 study of modified lenalidomide, bortezomib and dexamethasone in transplant-ineligible multiple myeloma'. Together they form a unique fingerprint.

Medicine & Life Sciences